In Brief This Week: iGenix, Illumina; Sigma-Aldrich; Becton Dickinson; UK's National Cancer Research Institute; SRU Biosystems | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Seattle-based iGenix has been named an Illumina certified service provider for the BeadXpress platform. iGenix said that it specializes in biomarker evaluation and helps clients develop new diagnostic assays for the BeadXpress platform.


Sigma-Aldrich said this week that its board of directors has declared a quarterly cash dividend of $.16 per share to be payable on Dec. 15 to shareholders of record on Dec. 1.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.